CF
BIOSU

Cantor Fitzgerald’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Cantor Fitzgerald’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-180,000
Closed -$2K – 808
2022
Q3 		$2K Hold
180,000
– – ﹤0.01% 774
2022
Q2 		$1.81M Hold
180,000
– – 0.04% 387
2022
Q1 		$0 Sell
180,000
-500,000
-74% -$5M ﹤0.01% 472
2021
Q4 		$6.8M Buy
+680,000
New +$6.81M 0.49% 44

Other funds holding BIOSU

HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cantor Fitzgerald's BIOSU Position: Q4 2022 in Review

Cantor Fitzgerald sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q4 2022, closing a stake of 180,000 shares — an estimated $2K sold.

Cantor Fitzgerald first reported a position in BIOSU in Q4 2021 and held it in 4 quarters. The position peaked at $6.8M in Q4 2021. 11 funds tracked by Wall St. Rank hold BIOSU as of Q4 2022.

  • Cantor Fitzgerald reported no remaining BioPlus Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
  • Cantor Fitzgerald sold 180,000 BioPlus Acquisition Corp. Unit shares in Q4 2022, an estimated $2K.
  • Cantor Fitzgerald first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
  • Cantor Fitzgerald's BioPlus Acquisition Corp. Unit position peaked at $6.8M in Q4 2021.
  • 11 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q4 2022.

Based on Cantor Fitzgerald's 13F filing for Q4 2022, filed 14 Feb 2023.